Showing results (1-10 of 121) with videos related to
Sort By:
Pageof 13
American Journal of Blood Research|March 21, 2012
The ubiquitin-proteasomal system is critical for multiple myeloma: implications in drug discoveryBiyin Cao, Xinliang MaoCurrent Pharmaceutical Design|November 16, 2012
Dissecting bortezomib: development, application, adverse effects and future directionBiyin Cao, Jie Li, Xinliang MaoBiochimica Et Biophysica Acta. Gene Regulatory Mechanisms|June 18, 2023
Ubiquitination is a major modulator for the activation of inflammasomes and pyroptosisQiuyun Jiang, Zhigang Zhu, Xinliang MaoMedical Hypotheses|December 3, 2010
Proteasome inhibitor clioquinol as a candidate drug in prophylaxis and treatment of acute graft-versus-host diseaseYong Liang, Xinliang Mao, Haiyan LiuDrug Discovery Today|April 11, 2015
Discovery of selective phosphatidylinositol 3-kinase inhibitors to treat hematological malignanciesJingyu Zhu, Tingjun Hou, Xinliang MaoThe British Journal of Nutrition|December 10, 2020
Glucose-lowering activity of dark tea protein extract by modulating spleen-brain axis of diabetic miceKeying Su, Xinliang Mao, Xuewu ZhangCurrent Pharmaceutical Design|May 30, 2018
The Emerging Roles of the HERC Ubiquitin Ligases in CancerXinliang Mao, Gautam Sethi, Zubin Zhang, et al.Current Pharmaceutical Design|September 5, 2013
The mTOR signaling pathway is an emerging therapeutic target in multiple myelomaJie Li, Jingyu Zhu, Biyin Cao, et al.Cancer Letters|June 14, 2022
Targeting the oncogenic transcription factor c-Maf for the treatment of multiple myelomaQiuyun Jiang, Hongwu Mao, Guisong He, et al.Pageof 13